New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 31, 2014
14:59 EDTINSY, ESRXInsys sinks after analyst sees drug to be excluded from coverage
Shares of Insys Therapeutic (INSY) are falling after Cleveland Research indicated that its checks showed Express Scripts (ESRX) was looking to exclude Insys' Subsys from its list of covered drugs for 2015. Express Scripts is a pharmacy benefits manager. Subsys is intended to provide pain relief for cancer patients. In mid-afternoon trading, Insys tumbled 8% to $27.68.
News For INSY;ESRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 28, 2015
06:27 EDTESRXExpress Scripts downgraded to Market Perform from Outperform at FBR Capital
Subscribe for More Information
January 26, 2015
08:11 EDTINSYInsys Therapeutics receives FDA ODD for LEP candidate
Insys Therapeutics announced that the FDA has granted orphan drug designation, or ODD, to its Liposomal Encapsulated Paclitaxel, or LEP, candidate for the treatment of ovarian cancer.
January 22, 2015
11:05 EDTINSYInsys Therapeutics granted orphan status for ovarian cancer treatment
Subscribe for More Information
January 21, 2015
10:28 EDTESRXLeerink pharmaceuticals analyst holds an analyst/industry conference call
Subscribe for More Information
10:01 EDTESRXOn the Fly: Analyst Initiation Summary
Subscribe for More Information
07:36 EDTESRXExpress Scripts initiated with an Equal Weight at Stephens
Subscribe for More Information
January 20, 2015
06:44 EDTESRXExpress Scripts downgraded to Neutral from Buy at UBS
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use